Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the EU to drive up ...

Pressure may grow on companies to repatriate production, raising production costs and potentially medicine prices too.

Johnson & Johnson (NYSE: JNJ), has broken ground on a $2 billion pharmaceutical manufacturing facility in Wilson, about 50 ...

Merck is planning layoffs in Pennsylvania as part of a multi-year plan to wind down operations at a manufacturing plant in ...

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

“Due to significant reductions in demand for these products, the company has decided to cease operations at the plant,” the ...

President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...

American pharmaceutical giant Johnson & Johnson (JNJ) is boosting its U.S. investments by 25% to more than $55 billion over ...